Effectiveness and Safety of Cannabidiol (100 mg Twice Daily) for Central Neuropathic Pain in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Preliminary Findings from a Multicentre Pilot study.

01/08/2026

Summary: Study on the use of Convupidiol in central neuropathic pain associated with multiple sclerosis and neuromyelitis optica spectrum disorder

Download PDF here

Back

This part of our web is reserved only for professionals as it contains information about prescription medications. Confirm you are a health professional to continue